NOD2 (CARD15) mutations in Crohn's disease are associated with diminished mucosal alpha-defensin expression
about
Central role of the gut epithelial barrier in the pathogenesis of chronic intestinal inflammation: lessons learned from animal models and human geneticsUse of antibiotics in the treatment of Crohn's diseaseDefects in mucosal immunity leading to Crohn's diseaseInnate immunity in inflammatory bowel disease: a disease hypothesisAntimicrobial activity of high-mobility-group box 2: a new function to a well-known proteinControl of NOD2 and Rip2-dependent innate immune activation by GEF-H1Recognition of Staphylococcus aureus by the innate immune system.Reduced Paneth cell alpha-defensins in ileal Crohn's diseaseSymbiotic bacteria direct expression of an intestinal bactericidal lectinFunction of Nod-like receptors in microbial recognition and host defenseA chromosome 8 gene-cluster polymorphism with low human beta-defensin 2 gene copy number predisposes to Crohn disease of the colonChronic inflammation: importance of NOD2 and NALP3 in interleukin-1beta generationInflammatory bowel disease related innate immunity and adaptive immunityMechanisms of Microbe-Host Interaction in Crohn's Disease: Dysbiosis vs. Pathobiont SelectionRegulation of the Intestinal Barrier Function by Host Defense PeptidesHost-microbiome interaction in Crohn's disease: A familiar or familial issue?Intestinal Microbiota and the Innate Immune System - A Crosstalk in Crohn's Disease PathogenesisMitochondrial dysfunction in inflammatory bowel diseaseInnate and adaptive immunity in inflammatory bowel diseaseAssociation among genetic predisposition, gut microbiota, and host immune response in the etiopathogenesis of inflammatory bowel diseaseAntimicrobial proteins in intestine and inflammatory bowel diseasesInnate immune sensing of microbes by Nod proteinsCEACAM6 gene variants in inflammatory bowel diseaseFaecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patientsGenetic variation in IBD: progress, clues to pathogenesis and possible clinical utilityGenotypes and phenotypes in Crohn's disease: do they help in clinical management?NLRP3 inflammasome plays a key role in the regulation of intestinal homeostasis.Paneth cell extrusion and release of antimicrobial products is directly controlled by immune cell-derived IFN-γ.Mucosal gene expression of antimicrobial peptides in inflammatory bowel disease before and after first infliximab treatment.The NOD2 single nucleotide polymorphisms rs2066843 and rs2076756 are novel and common Crohn's disease susceptibility gene variantsIntestinal mucus affinity and biological activity of an orally administered antibacterial and anti-inflammatory peptide.Analysis of NOD2-mediated proteome response to muramyl dipeptide in HEK293 cells.Human inflammatory bowel disease does not associate with Lawsonia intracellularis infectionCommon NOD2/CARD15 variants are not associated with susceptibility or the clinicopathologic characteristics of sporadic colorectal cancer in Hungarian patients.Functional characterization of two novel 5' untranslated exons reveals a complex regulation of NOD2 protein expression.Elevated systemic antibodies towards commensal gut microbiota in autoinflammatory condition.Genetic variants of Wnt transcription factor TCF-4 (TCF7L2) putative promoter region are associated with small intestinal Crohn's diseaseDysregulation of human beta-defensin-2 protein in inflammatory bowel disease.Disease phenotype and genotype are associated with shifts in intestinal-associated microbiota in inflammatory bowel diseasesIntroduction to the human gut microbiota
P2860
Q21131205-06D62A8C-0CB9-4F74-91A9-0D864AD70851Q22241216-F9341E72-3901-4498-A922-30719C3E0520Q22242645-7C7BA61C-47ED-46F0-8342-85FE7950703CQ22252859-1804B81C-065B-48C9-92CC-E5A28BD1AA0DQ24310791-0905223C-708B-482E-8B08-749839F272EBQ24337154-BADB795E-9327-4240-881C-9B83D17F7BE2Q24530569-AFEE63BE-BC87-4CB3-8DB4-9815129C12BDQ24538724-48493DE4-31D1-473E-8868-74182ECF56C4Q24644003-A2E6D093-6C25-47BC-9D8F-835F6FA8C69DQ24647448-F804825E-5377-4C74-8E8C-A3D729838C37Q24678661-BC4D381C-A8C9-4091-9462-B914972AE9B2Q24683293-C4CC39E4-2385-4307-95F0-A83A49351A66Q26741407-2F045E30-5F13-4503-B205-7D2A91A86E19Q26774688-608AC3FA-0484-4F38-83A2-0F1B0FA2BEDCQ26776055-23A6DF28-BA2D-4667-A915-D1B76E072E0AQ26776158-96182DC5-92F5-4EF8-9C5A-ED1F9640A96BQ26781239-6F2D6337-A5A0-4E3C-BD58-C5B10CF75C13Q26781311-FB60E64D-F8B2-4DA3-A847-10FF661E61ECQ26864276-DF6E8F2B-8E61-4DDC-AE75-66BABD93AF93Q27006589-CE50DC05-4782-4B3E-A1B6-DDA413F7401BQ27023239-BFFFC16A-E403-459E-B0DA-EEEDD924B63DQ28269979-DE8E18D7-7A57-46E8-B74A-8A6D918A22E9Q28740558-62322F9B-9DB2-490F-ACD4-2681F796BD84Q29614261-E004EC10-D506-40E1-8533-D73FCD879D65Q30251388-D3B62240-18A8-478B-998D-8F3E12B3D7B3Q30478821-09E178D3-A27C-49BC-8390-A44DF34114D0Q30497993-98F0899A-1DC5-44CA-A9F1-F9C643BBD749Q30582106-AD5967CD-FBCE-45E6-8762-A52419F35244Q30945619-E83198D3-AC27-42EE-B194-A366089646DEQ30994539-62987244-7D85-4DBF-A85D-ECA19FD6E46AQ31160852-D57E9604-9E2F-4522-8AD8-549BEDF73CE2Q33226252-9F7127FE-E056-4A5D-B89E-45734CBC2291Q33258058-FED7AFE6-C8C1-4A55-8065-262B4E83807CQ33280163-760713B7-13D0-4195-8258-4853E3EC3256Q33311590-D7D04233-C11E-4DDD-8EF1-F62A757D97AEQ33367939-6DB705CC-546A-46EA-8B9B-F0435CA97232Q33409853-F6137EED-18C5-40D6-83BC-3E34A6F9B4C0Q33484190-A0392A03-4803-4663-A007-23993FF6E949Q33691828-8510C54E-A44A-4A20-B5C4-A3D00EA80D50Q33693158-4480E497-B040-4E59-BDBC-6B1458978E71
P2860
NOD2 (CARD15) mutations in Crohn's disease are associated with diminished mucosal alpha-defensin expression
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
NOD2 (CARD15) mutations in Cro ...... osal alpha-defensin expression
@en
type
label
NOD2 (CARD15) mutations in Cro ...... osal alpha-defensin expression
@en
prefLabel
NOD2 (CARD15) mutations in Cro ...... osal alpha-defensin expression
@en
P2093
P2860
P356
P1433
P1476
NOD2 (CARD15) mutations in Cro ...... osal alpha-defensin expression
@en
P2093
A Stallmach
C L Bevins
E F Stange
E Schäffeler
J M Schröder
K Fellermann
K R Herrlinger
P2860
P304
P356
10.1136/GUT.2003.032805
P407
P50
P577
2004-11-01T00:00:00Z